< Previous page
All
Airlines/Aviation
Auto
Maritime/Shipbuilding
Transportation
Computer Hardware
Computer Networks
Computer Software
Computer/Electronics
Electronic Commerce
Electronic Components
High Tech Security
Internet Technology
Peripherals
Semiconductors
Electronics Gaming
Consumer Electronics
Mobile Entertainment
Multimedia/Online/Internet
Telecommunications
Household/Consumer/Cosmetics
Retail
Supermarkets
Toys
Alternative Energies
Chemical
Mining/Metals
Oil/Energy
Environmental Products & Services
Green Technology
Art
Cosmetics & Personal Care
Entertainment
Fashion
Film & Motion Picture
Jewelry
Banking/Financial Service
Insurance
Workforce Management/Human Resources
Education
Higher Education
Biotechnology
Health Care/Hospital
Infectious Disease Control
Medical Equipment
Medical/Pharmaceuticals
Agriculture
Machinery
Paper/Forest Products/Containers
Textiles
Domestic policy
Legal issues
Sports
Hotels and Resorts
Leisure/Travel/Hotels
Travel
Restaurants
Beer, Wine & Spirits
Beverages
Non-Alcoholic Beverages
Food/Beverages
Advertising
Books
Music
Publishing/Information Service
Television
Trade show news
Real Estate
Construction/Building
Furniture & Furnishings
|
Title only
|
Print
Next page >
88IV - PR Newswire Asia's news - Health Care/Hospital
5
CARES 4.0 Agent Debuts; Hospital Presidents from HK and Shenzhen Convene on AI Adoption; Bringing Together Medicine, Research, Industry, and Investment
—— The 4th CREATE Symposium Charts a Commercialization Path for the Future of Smart Healthcare ...
2026-10-06T
Health Care/Hospital
Medical Equipment
Trade show news
/C O R R E C T I O N -- Piramal Pharma Solutions/
In the news release, Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility, issued 06-Oct-2026 by Piramal Pharma Solutions over PR Newswire, we ...
2026-10-06T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins
Results from an 18-week, open-label Phase Ib trial of investigational Lu AF28996 in people with advanced Parkinson's disease are being presented at MDS 2026 The trial provided initial safety and tolerability ...
2026-10-06T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral-Care Innovation Rooted in Trans-Pacific Alder Research
Botanical oral-care product bridges 1974 Oregon State University discovery of 'oregonin' with 27 years of natural-product research by South Korean scientists. ...
2026-10-06T
Biotechnology
Cosmetics & Personal Care
Health Care/Hospital
Docquity Extends Asian Healthcare Intelligence to Japan Through Deepened Strategic Partnership with exMedio
Japan scale up advances Docquity's goal of Asian Healthcare Intelligence built on Clinical Intent, with Ask Dx as the core platform and "One Asia" linking physicians in Japan and Southeast ...
2026-10-06T
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Fapon Showcases High-Performance IVD Raw Materials at JACLaS EXPO 2026
KOBE, Japan , Oct. 6, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider, will showcase its one-stop IVD solution at JACLaS EXPO 2026, held October 8–10 in Kobe, Japan. Visit Booth B32, Hall 1, ...
2026-10-06T
Biotechnology
Health Care/Hospital
Medical Equipment
Medical/Pharmaceuticals
Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue
Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period ...
2026-10-05T
Computer Software
Computer/Electronics
Health Care/Hospital
Internet Technology
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform ...
2026-10-05T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
OMLYCLO ® (omalizumab-igec) is the first and only FDA-approved omalizumab biosimilar approved for all four indications of XOLAIR ® (omalizumab) and designated as interchangeable ...
2026-10-05T
Biotechnology
Health Care/Hospital
Medical/Pharmaceuticals
Habitat for Humanity's new global research report finds three in four people are cutting back on essentials to afford housing
ATLANTA , Oct. 5, 2026 /PRNewswire/ -- Housing costs are forcing millions of people around the world into difficult trade-offs, coming at the expense of food, healthcare, financial security and major ...
2026-10-05T
Banking/Financial Service
Construction/Building
Health Care/Hospital
< Previous page
Next page >
Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.